Louise Motala

Louise is CEO of Bridge Farm Bioscience.  She joined Bridge Farm Group in 2017 to support the growth of the business, including the £45m development of the Clay Lake glasshouse facility. She became Group Managing Director in 2019 and alongside developing the Horticulture business, she led the creation of Bridge Farm Bioscience.

Following five years of R&D, she recently oversaw the development of a £10m project, building a unique GMP compliant facility and has developed partnerships with global personal care and pharmaceutical businesses to commercialise Bridge Farm Bioscience’s activities.  Alongside scaling a business from R&D phase to commercialisation, she has direct experience of private equity ownership, being part a NASDAQ listed business and equity fundraising.